Balaxi Pharmaceuticals Ltd


1W Return


1M Return


6M Return


1Y Return


3Y Return


Start SIP in Balaxi Pharmaceuticals Ltd
Stock Performance
52 Week Low - High
Today’s Low - High


Prev. Close

Total Traded Value

View details of Market Depth

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
52.93% Gain from 52W Low
TTM PE Ratio
Negative PE TTM
Price to Book Ratio
Above industry Median
Dividend yield 1yr %
PEG TTM is slightly more than 1
RSI Overbought
MFI strongly Overbought

Balaxi Pharmaceuticals Ltd Key Financials

*All values are in ₹ Cr.

Balaxi Pharmaceuticals Ltd shareholding Pattern

Foreign Institutions

Balaxi Pharmaceuticals Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
Bearish Moving Averages
5Day EMA
10Day EMA
12Day EMA
20Day EMA
26Day EMA
50Day EMA
100Day EMA
200Day EMA
Delivery & Volume
Resistance & Support
First Resistance
Second Resistance
Third Resistance
First Support
Second support
Third Support
Relative Strength Index
Money Flow Index
MACD Signal
Average True Range
Average Directional Index
Rate of Change (21)
Rate of Change (125)

Balaxi Pharmaceuticals Ltd Company background

Founded in: 1942
Balaxi Ventures Limited (erstwhile known as The Anandam Rubber Company Limited) is a public limited company incorporated in India in September 28, 1942 with a basic objective of running rubber and tea plantations and owns several plantations across South India. In the year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading. The company previously was a investment company, but the company during the financial year 201819 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products Securities and Exchange Board of India (SEBI) vide Circular dated May 30, 2012 had issued revised Exit Policy for derecognized/nonoperational stock exchanges. Pursuant to the circular, Madras Stock Exchange has been derecognized by SEBI, recently. Further, as per above cited circular issued by SEBI on May 30, 2012, and Public Notice issued by Madras Stock Exchange Limited (MSE), it cleared that the Exclusively Listed Companies, which fail to obtain listing on any other stock exchange, will cease to be a listed company and will be moved to the Dissemination Board by the exiting stock exchange. Also, it is to be noted that SEBI has given a time limit of eighteen months for getting listed with any of the recognized stock exchanges. In pursuance to the above notice, the company has submitted listing application with National Stock Exchange of India (NSE) Limited on 19th January 2015 under listing criteria for Exclusively Listed Companies. The submitted listing application is under process with the National Stock Exchange of India (NSE) Limited and the company is hoping to be get listed very soon. Madras Stock Exchange has intimated the Company that it has been placed before Dissemination Board (DB) of National Stock Exchange of India (NSE) Limited. Under the Dissemination Board mechanism, a willing buyer and seller will be given an opportunity to disseminate their offers using the services of brokers of stock exchanges hosting Dissemination Board. On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.e. Mr. Nirej V. Paul, Mr. V. M. Paulose, Dr. Leelamma T. J and Mrs. Jaya Paul) to acquire 1,670,036 Equity Shares representing 54.94% of the paid up share capital of the Company along with the control over the Company, pursuant to which BOPL made an Open Offer under Regulation 3(1) and Regulation 4 of SEBI (SAST) Regulations, 2011. Control and management of the Company was acquired by BOPL on May 04, 2017 and it became the new promoter of Company and their representatives i.e. Mr. Ashish Maheshwari and Mrs. Minoshi Maheshwari became the new Directors of the Company. Simultaneously, erstwhile promoters stepped down as promoters from Company on same day and Mr. Nirej V. Paul and Dr. Leelamma TJ resigned as Managing Director and as Chairperson from the Company, respectively. Under the above said Open Offer, BOPL acquired 3,30,000 equity shares representing 10.86% equity share capital of the Company. On completion of the Open Offer BOPL became the holding and Promoter Company with an aggregate shareholding of 2000036 Equity Shares (ie 65.79%).The Company changed its name from The Anandam Rubber Company Limited to Balaxi Ventures Limited through Postal Ballot passed on August 08, 2017. It had also changed the Registered Office from 41/298 D2, 2nd Floor, Saniya Plaza, Mahakavi Bharathiyar Road, Near KSRTC Bus Stand, Cochin 682035 to Plot No.409, H.No. 82293, MAPS Towers, 3rd Floor, PhaseIII, Road No.81, Jubilee Hills, Hyderabad, Telangana, India 500096 through Postal Ballot passed on August 08, 2017.The main objects of the company were amended to include activities of International wholesale trading in pharmaceutical, food products and builders hardware by way of a Postal Ballot passed on August 08, 2018. The Company commenced the business of international wholesale trading in pharmaceuticals and builders hardware products starting September 2018. Further, in February 2019, The Company decided to kickstart its Food Products business by launching a range of biscuits under the brand YAP.The Board of the company approved the proposed preferential issue of 69,60,000 Equity shares on June 19, 2019 and subsequently obtained shareholders approval on July 12, 2019 via Extra Ordinary General Meeting. The Company had obtained required approvals from stock exchange and allotted 69,60,000 Equity shares on preferential basis on August 09, 2019. Consequently, the Paid up share capital of the company has been accordingly increased from Rs 3,04,00,000/ consisting of 30,40,000 Equity shares of Rs 10/ each to Rs 10,00,00,000/ consisting of 1,00,00,000 Equity shares of Rs 10/ each.
Read More

Balaxi Pharmaceuticals Ltd FAQs

The past 1-year return of Balaxi Pharmaceuticals Ltd [BALAXI] share was 14.11. The Balaxi Pharmaceuticals Ltd [BALAXI] share hit a 1-year low of Rs. 399.95 and a 1-year high of Rs. 686.3.

The market cap of Balaxi Pharmaceuticals Ltd is Rs. 625.73 Cr. as of 2/21/2024 12:00:00 AM.

The PE ratios of Balaxi Pharmaceuticals Ltd is 76.65 as of 2/21/2024 12:00:00 AM.

The PB ratios of Balaxi Pharmaceuticals Ltd is 6.41 as of 2/21/2024 12:00:00 AM

You can easily buy Balaxi Pharmaceuticals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -